Abstract
The ability of the alpha-1 adrenoceptor antagonist, prazosin, to reduce the severity and duration of episodes of autonomic dysreflexia was studied in cervical and high thoracic spinal cord injury patients with documented episodes of autonomic dysreflexia. Sixteen patients participated in a double blind parallel group study comparing prazosin 3 mg b.d. with placebo given for 2 weeks. Both groups were matched for age, sex and baseline severity of autonomic dysreflexia episodes. Prazosin was well tolerated and did not produce a significant lowering of resting blood pressure. Compared to baseline measurements, patients allocated to prazosin therapy were found to have fewer severe episodes of autonomic dysreflexia and during these episodes to have significant reductions in average rise in systolic and diastolic blood pressure, symptom duration and requirement for acute antihypertensive medication. The severity of headache during individual autonomic dysreflexia episodes was also diminished with prazosin therapy. No symptom parameter was significantly altered by placebo therapy. It is concluded that prazosin is superior to placebo in the prophylactic management of autonomic dysreflexia and that these findings are consistent with suggestions that alpha-1 adrenoceptors play an important role in the pathogenesis of this syndrome.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Mathias CJ, Frankel HL. Autonomic disturbances in spinal cord lesions. In Bannister R and Mathias CJ, eds.Autonomic Failure. A textbook of disorders of the autonomic nervous system.3rd Edition. Oxford: Oxford University Press, 1992;10: 837–879.
Krum H, Howes LG, Rowe PR, Brown DJ, Louis WJ. Steady state plasma [3H] noradrenaline kinetics in quadriplegic chronic spinal cord injury patients.J Auton Pharmacol 1988;10: 220–226.
Mathias CJ, Frankel HL, Christensen NJ, Spalding JMK. Enhanced pressor response to noradrenaline in patients with cervical spinal cord transection.Brain 1976;99: 757–770.
Krum H, Louis WJ, Brown DJ, Howes LG. Pressor dose responses and baroreflex sensitivity in tetraplegic spinal cord injury patients.J Hypertension 1992;10: 245–250.
Mathias CJ, Frankel HL. Cardiovascular control in spinal man.Ann Rev Physiol 1988;50: 577–592.
Mathias CJ, Christensen NJ, Corbett JL, Frankel HL, Spalding JMK. Plasma catecholamines during paroxysmal neurogenic hypertension in tetraplegic men.Circ Res 1976;39: 204–208.
Sumner DJ, Elliott HL, Vincent J, Reid JL. A pragmatic approach to the pressor dose response as an index of vascular reactivity and adrenoceptor function in man.Br J Clin Pharmacol 1987;23: 505–510.
Krane RJ, Olsson C. Phenoxybenzamine in neurogenic bladder dysfunction. 1. A theory of micturition.J Urol 1973;110: 650–652.
Krane RJ, Olsson C. Phenoxybenzamine in neurogenic bladder dysfunction. 2. Clinical considerations.J Urol 1973;110: 653–656.
Blaivas JG, Sinha HP, Zayed AAH, Cabib KB. Detrusor-external sphincter dyssynergia: a detailed electromyographic study.J Urol 1981;125: 542–545.
Gosling JA, Dixon JS, Lendo RG. The autonomic innervation of the human male and female bladder neck and proximal urethra.J Urol 1977;118: 302–305.
Gajewski J, Downie J, Awad S. Experimental evidence for a central nervous system site of action in the effect of alpha adrenergic blockers on the external urethral sphincter.J Urol 1984;133: 403.
Thompson CE, Whitham AC. Paroxysmal hypertension in spinal cord injuries.N Engl J Med 1948;239: 291–294.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krum, H., Louis, W.J., Brown, D.J. et al. A study of the alpha-1 adrenoceptor blocker prazosin in the prophylactic management of autonomic dysreflexia in high spinal cord injury patients. Clinical Autonomic Research 2, 83–88 (1992). https://doi.org/10.1007/BF01819662
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01819662